{"id":"https://openalex.org/A5118963459","orcid":"https://orcid.org/0009-0002-3583-6871","observed_orcids":["https://orcid.org/0009-0002-3583-6871"],"display_name":"Dharani Sai Sreekanth Nellore","raw_author_names":["Dharani Sai Sreekanth Nellore","Nellore, Dharani Sai Sreekanth"],"full_name":"Nellore, Dharani Sai Sreekanth","works_count":6,"cited_by_count":12,"summary_stats":{"2yr_mean_citedness":2.0,"h_index":1,"i10_index":1},"ids":{"openalex":"https://openalex.org/A5118963459","orcid":"https://orcid.org/0009-0002-3583-6871","observed_orcids":["https://orcid.org/0009-0002-3583-6871"]},"affiliations":[{"institution":{"id":"https://openalex.org/I21250087","ror":"https://ror.org/024d6js02","display_name":"Charles University","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]},"years":[2026,2025]}],"last_known_institutions":[{"id":"https://openalex.org/I21250087","ror":"https://ror.org/024d6js02","display_name":"Charles University","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]}],"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","count":5,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","count":5,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","count":2,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","count":2,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","count":1,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","value":5.76e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","value":1.93e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","value":1.68e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","value":7e-06,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","value":6.6e-06,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"132040763","wikidata":"https://www.wikidata.org/wiki/Q409867","display_name":"Pregnane X receptor","score":0.9824419021606445},{"id":"2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","score":0.6592000126838684},{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.6209080815315247},{"id":"98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","score":0.539662778377533},{"id":"170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","score":0.38929998874664307}],"counts_by_year":[{"year":2025,"works_count":2,"oa_works_count":2,"cited_by_count":1},{"year":2026,"works_count":4,"oa_works_count":3,"cited_by_count":11}],"display_name_alternatives":["Dharani Sai Sreekanth Nellore","Nellore, Dharani Sai Sreekanth"],"block_key":"d nellore","works_api_url":"https://api.openalex.org/works?filter=author.id:A5118963459","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5118963459","updated_date":"2026-11-09T14:06:01","created_date":"2025-10-10T00:00:00"}